✦ LIBER ✦

Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis

✍ Scribed by Mascarenhas, J.; Hoffman, R.

Book ID: 115440319
Publisher: American Association for Cancer Research
Year: 2012
Tongue: English
Weight: 428 KB
Volume: 18
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-11-3145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ruxolitinib for the Treatment of Myelofi

Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal

✍ Wade, Ros; Rose, Micah; Neilson, Aileen Rae; Stirk, Lisa; Rodriguez-Lopez, Rocio 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 276 KB

Current FDA-Approved Treatments for Heli

Current FDA-Approved Treatments for Helicobacter pylori and the FDA Approval Process

✍ Robert J. Hopkins 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 545 KB

FDA approvals for the first 6 months of

FDA approvals for the first 6 months of 2014

📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 593 KB

The first FDA-approved treatment for ant

The first FDA-approved treatment for anthracycline extravasation: bringing Totect onboard, and paying for it

✍ Carla Brutico 📂 Article 📅 2008 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 62 KB

Velcade(R): U.S. FDA Approval for the Tr

Velcade(R): U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy

✍ Kane, R. C. 📂 Article 📅 2003 🏛 Alphamed Press 🌐 English ⚖ 89 KB

Optimizing management of ruxolitinib in

Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing

✍ Mesa, Ruben A; Cortes, Jorge 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 219 KB